Latanoprost 50micrograms/ml eye drops

Quốc gia: Vương quốc Anh

Ngôn ngữ: Tiếng Anh

Nguồn: MHRA (Medicines & Healthcare Products Regulatory Agency)

Thành phần hoạt chất:

Latanoprost

Sẵn có từ:

Kent Pharma (UK) Ltd

Mã ATC:

S01EE01

INN (Tên quốc tế):

Latanoprost

Liều dùng:

50microgram/1ml

Dạng dược phẩm:

Eye drops

Tuyến hành chính:

Ocular

Lớp học:

No Controlled Drug Status

Loại thuốc theo toa:

Valid as a prescribable product

Tóm tắt sản phẩm:

BNF: 11060000; GTIN: 5060061161534

Tờ rơi thông tin

PACKAGE LEAFLET: INFORMATION FOR THE
USER
LATANOPROST -
50 MICROGRAMS/ML EYE DROPS SOLUTION
LATANOPROST THIS MEDICINE. EVEN IF YOU HAVE ALREADY USED LATANOPROST OR A SIMILAR MEDICINE BEFORE, WE ADVISE YOU TO READ THIS TEXT CAREFULLY. THE INFORMATION MAY HAVE BEEN CHANGED.
- If you have any further questions, ask your doctor or the
doctor treating your child or your pharmacist.
- This medicine has been prescribed for you or for your child.
Do not pass it on to others. It may harm them, even if
their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any
or the doctor treating your child or your pharmacist. See
section 4.
1. What LATANOPROST is and what it is used for
2. Before you use LATANOPROST
3. How to use LATANOPROST
4. Possible side effects
5. How to store LATANOPROST
6. Further information
1.
WHAT LATANOPROST IS AND WHAT IT
IS USED FOR
LATANOPROST is a medicine for the treatment of increased
intraocular pressure (pressure inside the eye). The active
ingredient Latanoprost is one of a group of medicines known
as prostaglandins.
Fluid known as aqueous humour is produced inside the eye.
maintaining the required pressure within the eye. If this
humour.
LATANOPROST IS USED:
- to reduce inner eye pressure in patients with open-angle
glaucoma (damage to the optic nerve, caused by excessive
pressure within the eye).
- to reduce inner eye pressure in patients who suffer from a
condition known as ocular hypertension.
LATANOPROST is also used to treat increased eye pressure and
glaucoma in all ages of children and babies.
2. BEFORE YOU USE LATANOPROST
LATANOPROST can be used in adult men and women (including
the elderly) and in children from birth to 18 years of age.
LATANOPROST has not been investigated in prematurely born
infants (less than 36 weeks gestation).
DO NOT USE LATANOPROST
- if you are allergic (hypersensitive) to latanoprost, or any of
the other ingredients of LATANOPROST (see section 6.
”Further information”).
- if you are pregnant or trying to become pregnan

Đặc tính sản phẩm

OBJECT 1
LATANOPROST 50MCG/ML EYE DROPS
Summary of Product Characteristics Updated 19-May-2017 | Beacon
Pharmaceuticals
1. Name of the medicinal product
Latanoprost 50 micrograms/ml eye drops solution
2. Qualitative and quantitative composition
One ml eye drops solution contains 50 micrograms of latanoprost.
One drop contains approximately 1.5 micrograms latanoprost.
Excipient: Benzalkonium chloride 0.2 mg/ml
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Eye drops, solution.
Clear, colourless, sterile aqueous solution with a pH of 6.7 ±0.1 and
an osmolality between 260 and 330
mOsmol/kg.
4. Clinical particulars
4.1 Therapeutic indications
Reduction of elevated intraocular pressure in patients with open angle
glaucoma and ocular hypertension.
Reduction of elevated intraocular pressure in paediatric patients with
elevated intraocular pressure and
paediatric glaucoma.
4.2 Posology and method of administration
Ocular use
_Recommended dosage for adults (including the elderly):_
Recommended therapy is one eye drop in the affected eye(s) once daily.
Optimal effect is obtained if
latanoprost is administered in the evening.
The dosage of latanoprost should not exceed once daily since it has
been shown that more frequent
administration decreases the intraocular pressure lowering effect.
If one dose is missed, treatment should continue with the next dose as
normal.
As with any eye drops, to reduce possible systemic absorption, it is
recommended that the lachrymal sac
be compressed at the medial canthus (punctal occlusion) for one
minute. This should be performed
immediately following the instillation of each drop.
Contact lenses should be removed before instillation of the eye drops
and may be reinserted after 15
minutes.
If more than one topical ophthalmic medicinal product is being used,
the medicinal products should be
administered at least five minutes apart.
_Paediatric population:_
Latanoprost eye drops solution may be used in paediatric patients at
the same posology as in adults. No
data are